Monday, July 6, 2015

Canine cancer fighting drug shows promise

Illinois researchers are optimistic that a new anti-cancer drug is helping dogs live longer - and may one day help humans.

Canine cancer fighting drug shows promise



Illinois researchers are optimistic that a new anti-cancer drug is helping dogs live longer  - and may one day help humans.

A chemistry professor at the Univeristy of Illinois-Champaign has developed a drug compound known as PAC-1 that has shown promising results in test subjects.

 The drug essentially causes cancer cells to self-destruct by targeting an enzyme found in many types of cancer, said its creator Paul Hergenrother.

"It gives cancer cells a signal to commit suicide," he told The News-Gazette of Champaign.

One test subject's owner says the drug gave him another 18 months with his golden retriever Blaze.

"It gave us an extra year, year-and-a-half with our pet," said Phill Meyer. "If we'd done nothing, she wouldn't have lasted a month. With the chemo and the PAC, it did a great deal of help for her, more than anything else."

The newspaper said the drug is being considered by the U.S. Food and Drug Administration for human trials on patients with brain cancer.

(Photo/The News-Gazette)


Inquirer Staff Writer
We encourage respectful comments but reserve the right to delete anything that doesn't contribute to an engaging dialogue.
Help us moderate this thread by flagging comments that violate our guidelines.

Comment policy: comments are intended to be civil, friendly conversations. Please treat other participants with respect and in a way that you would want to be treated. You are responsible for what you say. And please, stay on topic. If you see an objectionable post, please report it to us using the "Report Abuse" option.

Please note that comments are monitored by staff. We reserve the right at all times to remove any information or materials that are unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane, indecent or otherwise objectionable. Personal attacks, especially on other participants, are not permitted. We reserve the right to permanently block any user who violates these terms and conditions.

Additionally comments that are long, have multiple paragraph breaks, include code, or include hyperlinks may not be posted.

Read 0 comments
comments powered by Disqus
About this blog

Amy Worden Inquirer Staff Writer
Latest Videos:
Also on
letter icon Newsletter